QUT ePrints

Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?

Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.

View at publisher

Impact and interest:

12 citations in Scopus
Search Google Scholar™
7 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 44336
Item Type: Journal Article
Keywords: Alcoholism, CB1 Receptor Antagonist, CB1 Receptor, Obesity, Rimonabant, Sardinian Alcohol-Preferring Rats, SR-147778
DOI: 10.1517/13543784.14.3.339
ISSN: 1354-3784
Subjects: Australian and New Zealand Standard Research Classification > BIOLOGICAL SCIENCES (060000) > BIOCHEMISTRY AND CELL BIOLOGY (060100)
Australian and New Zealand Standard Research Classification > BIOLOGICAL SCIENCES (060000) > MICROBIOLOGY (060500)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500)
Deposited On: 24 Aug 2011 22:10
Last Modified: 29 Feb 2012 13:59

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page